Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

State Medicaid Proposals Stymied By Push For New Drug Formulary Exemption

Executive Summary

Pharmaceutical industry support for language that would temporarily exempt new drugs from formularies appears to have blocked the latest attempt by states to develop Medicaid prior authorization programs

You may also be interested in...



Medicaid Preferred Drug Lists: Florida Suit Will Test Quality Arguments

A class action lawsuit brought by the Florida public defender against the state Medicaid program will test the limits of state preferred drug lists, Health Strategies Consultancy Managing Director Dan Mendelson predicted

Medicaid Preferred Drug Lists: Florida Suit Will Test Quality Arguments

A class action lawsuit brought by the Florida public defender against the state Medicaid program will test the limits of state preferred drug lists, Health Strategies Consultancy Managing Director Dan Mendelson predicted

Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court

Maine's Medicaid waiver program qualifies for manufacturer rebates because of the state's contribution to beneficiaries' prescription costs, the D.C. federal court decided Feb. 25

Related Content

UsernamePublicRestriction

Register

PS039679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel